BRCA2 c.4034del ;(p.D1345Vfs*29)

Variant ID: 13-32912526-GA-G

NM_000059.3(BRCA2):c.4034del;(p.D1345Vfs*29)

This variant was identified in 5 publications

View GRCh38 version.




Publications:


Prevalence of specific and recurrent/founder pathogenic variants in BRCA genes in breast and ovarian cancer in North Africa.

Bmc Cancer
ElBiad, Oubaida O; Laraqui, Abdelilah A; El Boukhrissi, Fatima F; Mounjid, Chaimaa C; Lamsisi, Maryame M; Bajjou, Tahar T; Elannaz, Hicham H; Lahlou, Amine Idriss AI; Kouach, Jaouad J; Benchekroune, Khadija K; Oukabli, Mohammed M; Chahdi, Hafsa H; Ennaji, Moulay Mustapha MM; Tanz, Rachid R; Sbitti, Yassir Y; Ichou, Mohammed M; Ennibi, Khalid K; Badaoui, Bouabid B; Sekhsokh, Yassine Y
Publication Date: 2022-02-25

Variant appearance in text: BRCA2: 4034delA
PubMed Link: 35216584
Variant Present in the following documents:
  • Main text
  • 12885_2022_Article_9181.pdf
View BVdb publication page



Pharmacogenetics of toxicity of 5-fluorouracil, doxorubicin and cyclophosphamide chemotherapy in breast cancer patients.

Oncotarget
Tecza, Karolina K; Pamula-Pilat, Jolanta J; Lanuszewska, Joanna J; Butkiewicz, Dorota D; Grzybowska, Ewa E
Publication Date: 2018-02-06

Variant appearance in text: BRCA2: 4034delA
PubMed Link: 29507678
Variant Present in the following documents:
  • Main text
  • oncotarget-09-9114.pdf
View BVdb publication page



Mutations in context: implications of BRCA testing in diverse populations.

Familial Cancer
Felix, Gabriela E S GES; Zheng, Yonglan Y; Olopade, Olufunmilayo I OI
Publication Date: 2018-10

Variant appearance in text: BRCA2: 4034delA
PubMed Link: 28918466
Variant Present in the following documents:
  • Main text
View BVdb publication page



Genetic polymorphisms and response to 5-fluorouracil, doxorubicin and cyclophosphamide chemotherapy in breast cancer patients.

Oncotarget
Tecza, Karolina K; Pamula-Pilat, Jolanta J; Lanuszewska, Joanna J; Grzybowska, Ewa E
Publication Date: 2016-10-11

Variant appearance in text: BRCA2: 4034delA
PubMed Link: 27527855
Variant Present in the following documents:
  • Main text
  • oncotarget-07-66790.pdf
View BVdb publication page



High proportion of recurrent germline mutations in the BRCA1 gene in breast and ovarian cancer patients from the Prague area.

Breast Cancer Research : Bcr
Pohlreich, Petr P; Zikan, Michal M; Stribrna, Jana J; Kleibl, Zdenek Z; Janatova, Marketa M; Kotlas, Jaroslav J; Zidovska, Jana J; Novotny, Jan J; Petruzelka, Lubos L; Szabo, Csilla C; Matous, Bohuslav B
Publication Date: 2005

Variant appearance in text: BRCA2: 4034delA
PubMed Link: 16168118
Variant Present in the following documents:
  • Main text
  • bcr1282.pdf
View BVdb publication page